𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer

✍ Scribed by Mary A. Bewick; Michael S. C. Conlon; Robert M. Lafrenie

Publisher
Springer US
Year
2009
Tongue
English
Weight
139 KB
Volume
117
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Circulating interleukin-6 predicts survi
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra

Survival of patients with metastatic bre
Survival of patients with metastatic breast cancer diagnosed between 1955 and 1980
✍ Daniel Debonis; Jose J. Terz; Samuel Eldar; L. Robert Hill πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

## Abstract In order to determine whether current programs for the management of metastatic breast cancer have led to improved patient survival, we determined the median survival times for five‐year intervals of 849 patients admitted to the City of Hope National Medical Center with metastatic breas